GuangYuYuan(SH:600771) Xin Lang Cai Jing·2025-11-07 05:25Core Viewpoint - Guangyuyuan's stock price has shown a modest increase this year, with a notable rise in recent trading days, reflecting positive market sentiment and financial performance [2][3]. Group 1: Stock Performance - As of November 7, Guangyuyuan's stock price increased by 2.30%, reaching 20.05 CNY per share, with a trading volume of 1.58 billion CNY and a turnover rate of 1.62% [1]. - Year-to-date, Guangyuyuan's stock price has risen by 6.31%, with a 4.75% increase over the last five trading days and a 3.78% increase over the last 20 days, although it has decreased by 4.89% over the last 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Guangyuyuan achieved a revenue of 1.061 billion CNY, representing a year-on-year growth of 18.71%, while the net profit attributable to shareholders was 78.884 million CNY, up 11.16% year-on-year [2]. - The company's main business revenue composition includes traditional Chinese medicine (72.19%), premium Chinese medicine (24.20%), health wine (3.55%), and other (0.06%) [2]. Group 3: Shareholder and Institutional Holdings - As of September 30, 2025, the number of shareholders for Guangyuyuan increased to 65,300, up by 2.85%, with an average of 7,495 circulating shares per person, a decrease of 2.77% [2]. - The top ten circulating shareholders include notable entities such as Southern CSI 1000 ETF and Hong Kong Central Clearing Limited, with some holdings experiencing slight reductions while others, like Penghua Medical Technology Stock A, are new entrants [3].